Limited Offer
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Nanotechnological Applications in Virology
- 1st Edition - June 23, 2022
- Editors: Mahendra Rai, Alka Yadav
- Language: English
- Paperback ISBN:9 7 8 - 0 - 3 2 3 - 9 9 5 9 6 - 2
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 9 9 5 9 7 - 9
Nanotechnological Applications in Virology explores the use of nanoparticles-based technologies to fight against viruses, also discussing the use of nanoparticles in the preparati… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteNanotechnological Applications in Virology explores the use of nanoparticles-based technologies to fight against viruses, also discussing the use of nanoparticles in the preparation of nano masks and as sanitizing agents. The role of nanotechnology against HIV, Hepatitis, Influenza, Herpes, Ebola and Zika using rapid detection and diagnostic techniques is included, as is a brief description of SARS, MERS, the novel Coronavirus, and recent advancements in its treatment process. Other sections cover the formulation of novel nano-vaccines for the treatment and control of viral infections like HIV, Hepatitis and COVID-19. Included toxicological studies of nanoparticles provide readers with a brief overview on global scenarios regarding viral infections.
Nanotechnology is the present age technology, with wide usage in different areas of medical science, including drug delivery, gene therapy, antimicrobials, biosensors and bio-labelling. Nanoparticles play a competent role as an anti-infection agent and thus act as efficient antiviral agents.
- Mitochondria as a Key Intracellular Target of Thallium Toxicity presents a new hypothesis that explains the decrease in antioxidant defense in thallium poisoning. In addition, the book proposes a new model for studying the transport of inorganic cations across the inner mitochondrial membrane. Readers will learn about the toxicity of thallium and its compounds, the toxicology of thallium, the toxic thallium effects on cells, and the effects of thallium on mitochondria. This book+J136 lists the pathways and mechanisms of thallium transport into cells and mitochondria. This toxicity has been analyzed at both the cellular and subcellular levels
- The increase in human contact with the toxic trace element thallium is associated with developments in industry, the release of this metal into the environment from various rocks, and the use of special isotope techniques for studying the vascular bed
Post-graduate students, researchers, and scientists working in the field of nanotechnology, nanotechnology-based application technologies and viral infections. Medical researchers and pharmaceutical companies working to develop nano-based detection and diagnostic kits, sanitizing agents, etc. and scientists working on the development of vaccine strategies
- Cover image
- Title page
- Table of Contents
- Copyright
- Contributors
- Preface
- Chapter 1: Nanotechnological applications in old and emerging viral infections: Opportunities and challenges
- Abstract
- Acknowledgments
- 1: Introduction
- 2: Diversity in viral infections
- 3: Nanoweapons against viral crusaders
- 4: Challenges ahead
- 5: Overcoming challenges
- 6: Conclusions
- References
- Further reading
- Chapter 2: Nanotechnology-based innovations to fight against viral infections
- Abstract
- 1: Introduction
- 2: Types of nanocarriers
- 3: Nanomedicine and COVID-19
- 4: Viruses as nanocarriers
- 5: Viruses used in the treatment of cancer
- 6: ZnO nanoparticles used in treatment of the H1N1 influenza virus
- 7: Nanomedicine as a diagnostic agent of hepatitis C virus
- 8: Conclusions
- References
- Further reading
- Chapter 3: Unique advantages of nanomaterials in drug delivery and therapy against viruses
- Abstract
- Acknowledgments
- 1: Introduction
- 2: Main viral diseases in humans
- 3: Nanomaterials (NMs) in viral therapy
- 4: The action of NMs in the structure of viruses
- 5: Scheme of the nanomaterial drug delivery system
- 6: Conclusion
- References
- Chapter 4: Application of nanomaterials as nano-masks
- Abstract
- 1: Introduction
- 2: Classification of face masks
- 3: Issues related to bulk material-based masks
- 4: Nano-masks
- 5: Characteristics of nano-masks
- 6: Nanomaterials used for fabrication of nano-masks
- 7: Issues related to the use of nano-masks
- 8: Conclusions and final remarks
- References
- Chapter 5: Personal protective equipment to protect from viruses
- Abstract
- 1: Introduction
- 2: Evaluation of mask efficiency
- 3: Conventional masks
- 4: Nano-based face masks
- 5: Sanitizers
- 6: Virus-disinfectant general interaction
- 7: Alcohol-based sanitizers
- 8: Nonalcohol-based sanitizers
- 9: Pathogen resistance due to sanitizer overuse
- 10: Nano-based sanitizer
- 11: Conclusions
- References
- Chapter 6: Nanotherapy approach to target ZIKA virus in microglia: A case study
- Abstract
- Acknowledgment
- 1: Introduction
- 2: Exploring a novel drug delivery platform for neurological diseases
- 3: A novel case study to examine the efficacy of a nano-neurotherapeutic for ZIKA
- 4: Perspectives
- 5: Conclusions
- References
- Chapter 7: Nanotechnology: New frontiers in anti-HIV therapy
- Abstract
- Acknowledgment
- 1: Introduction
- 2: What are viruses?
- 3: Antiviral drugs
- 4: Benefits of nanomaterials and nanoformulations
- 5: Nanoformulated drugs
- 6: Fixed-dose multiple drug combinations
- 7: Other anti-HIV effective formulations
- 8: Conclusions
- References
- Chapter 8: Nanoparticle-based immunoassays for early and rapid detection of HIV and other viral infections
- Abstract
- 1: Introduction
- 2: Viruses: Nanoscale pathogens
- 3: Nanotechnology and virus detection
- 4: Conjugation of NPs to biomolecules
- 5: Conclusions and future perspectives
- References
- Chapter 9: Potential role of nanotechnology in the treatment of influenza and hepatitis viruses
- Abstract
- 1: Introduction
- 2: Nanotechnology
- 3: Influenza viruses
- 4: Hepatitis viruses
- 5: Nanotechnology target influenza
- 6: Nanotechnology to target hepatitis
- 7: Conclusions and final remarks
- References
- Chapter 10: Nanoformulations: A novel approach for effective management of vector-borne viral diseases
- Abstract
- Acknowledgments
- 1: Introduction
- 2: Drawbacks of current treatment strategies for some vector-borne viral diseases
- 3: Need of nanoformulation for the effective management of vector-borne viral diseases
- 4: Advantages of nanoformulation techniques for vector-borne viral diseases
- 5: Application of nanotechnology in the management and fight against vector-borne viral diseases
- 6: Other applications of nanotechnology to control vectors
- 7: Various nanosystems used in vector-borne viral diseases
- 8: Nanoformulations in the treatment of vector-borne viral diseases
- 9: Role of nanotechnology in detection of vector-born viral diseases
- 10: Future perspectives
- 11: Conclusions
- References
- Chapter 11: SARS, MERS, nSARS-CoV-2 infections and diseases: Emerging threats to public health
- Abstract
- 1: Viral infection and human disease
- 2: Coronaviruses and family
- 3: SARS-CoV
- 4: MERS-CoV
- 5: Novel SARS-CoV-2
- 6: Genomics and proteomics of coronaviruses
- 7: Risk factors
- 8: Therapeutics and immunization
- 9: Limitations and challenges
- 10: Conclusions and future perspectives
- References
- Further reading
- Chapter 12: Origin, evolution, and pathogenesis of coronaviruses
- Abstract
- 1: Introduction
- 2: Origin and evolution of coronaviruses
- 3: Pathogenesis of coronaviruses
- 4: Conclusions and perspective
- References
- Chapter 13: Recent advancements and nanotechnological interventions in diagnosis, treatment, and vaccination for COVID-19
- Abstract
- 1: Introduction
- 2: Diagnostics
- 3: Treatments
- 4: Vaccination
- 5: Nano-based advancements in COVID-19
- 6: Concluding remarks
- References
- Further reading
- Chapter 14: Strategies on functionalization of organic and inorganic nanocarriers to inactivate SARS-CoV-2
- Abstract
- 1: Introduction
- 2: Inorganic nanocarriers
- 3: Organic nanocarriers
- 4: Functionalized nanocarriers
- 5: Conclusions and future perspectives
- References
- Chapter 15: Nanovaccines against viral infections: Current trends and future prospects
- Abstract
- 1: Introduction
- 2: Immune response against microbes
- 3: Immune response to vaccines
- 4: Nanocarriers for vaccine delivery
- 5: Conclusion and future perspectives
- References
- Further reading
- Chapter 16: Development of novel vaccines using nanomaterials against COVID-19
- Abstract
- 1: Introduction
- 2: Nanomaterials for nanoenemies (COVID-19)
- 3: COVID-19 vaccine
- 4: Differences in traditional and COVID-19 vaccine design
- 5: Potential nanoadjuvants for the development of a SARS-Cov-2 vaccine
- 6: Diversity in vaccine platforms
- 7: Classical vaccine platforms
- 8: Nanotechnology role in vaccine administration
- 9: Activation of dendritic cells
- 10: Nanomaterial for targeting lymph node
- 11: Nanomaterials for altered vaccine efficacy by microbiome
- 12: Conclusions and future prospects
- References
- Further reading
- Index
- No. of pages: 364
- Language: English
- Edition: 1
- Published: June 23, 2022
- Imprint: Academic Press
- Paperback ISBN: 9780323995962
- eBook ISBN: 9780323995979
MR
Mahendra Rai
Professor Mahendra Rai is a UGC-Basic Science Research Faculty Fellow and former head of the Department of Biotechnology, Sant Gadge Baba Amravati University, India. Presently, he is a visiting Scientist at the Department of Microbiology, Nicolaus Copernicus University, Poland. His areas of expertise include microbial biotechnology and nanobiotechnology. Currently, his group’s main research interest is green synthesis of metal nanoparticles particularly using fungi and their applications as nanoantimicrobials against pathogenic microbes. Prof. Rai has received several prestigious awards, including the Medini Award by the Government of India. He has been featured in Stanford’s list of the top 2% of scientists in nanoscience.
Affiliations and expertise
Visiting Scientist, Nicolaus Copernicus University, Torun, PolandAY
Alka Yadav
Dr Yadav PhD has 10 years of experience in publishing research and review articles in high impact factor journals. She has worked as guest reviewer in prestigious science publications such as Springer, Wiley, Taylor and Frances and has been recognized by Elsevier for her article Silver nanoparticles: as a new generation of antimicrobials which has been cited over 5000 times. She has several book chapters along with a process patent to her credit
Affiliations and expertise
Department of Biotechnology, SGB Amravati University, India